Implications of the partial volume effect correction on the spatial quantification of hypoxia based on [18F]FMISO PET/CT data

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Kafkaletos, Athanasios
  • Sachpazidis, Ilias
  • Mix, Michael
  • Schaefer, Henning
  • Ruehle, Alexander
  • Nicolay, Nils H.
  • Lazzeroni, Marta
  • Toma-Dasu, Iuliana
  • Grosu, Anca L.
  • Baltas, Dimos

Grupos

Abstract

Purpose: This study evaluates the impact of partial volume effect (PVE) correction on [F-18]fluoromisonidazole (FMISO) PET images, focusing on the conversion of standardized uptake values (SUV) to partial oxygen pressure (pO(2)) and the subsequent determination of hypoxic tumor volume (HTV). Methods: FMISO PET images from 49 head and neck squamous cell carcinoma cases were retrospectively corrected for PVE and converted to pO(2). A pO(2) threshold of 10 mmHg was used to delineate the HTV (HTVpO2). Comparisons of pO(2) distribution and HTVpO2 between corrected and uncorrected images were made, with pO(2) distributions evaluated against published polarographic data. HTVpO2 was compared to HTV defined by the conventional tumor-to-muscle ratio (TMR) method (HTVTMR) in terms of volume and topography (DICE coefficient, Hausdorff distance, and center-of-gravity distance) across different TMR cutoff levels. The cutoff level where the segmentation results from both methods were most similar was identified (TMRbest). Results: The PVE correction led to decreased minimum pO(2), increased HTVpO2 and the identification of more hypoxic cases (HTV > 0). The pO(2) distribution demonstrated improved alignment with published polarographic data. At TMRbest 1.6, the center-of-gravity distance between HTVTMR and HTVpO2 demonstrated a low median at 1.5 mm, while the wide range (0.0 to 9.6 mm) indicated high interpatient variability. The shape of HTV exhibited considerable variation with DICE 0.74 (0.03 to 1.00) and Hausdorff distance 8.5 mm (2.0 to 42.8 mm). Conclusions: PVE correction is recommended before converting SUV to pO(2) for the spatially resolved quantification of hypoxia

Datos de la publicación

ISSN/ISSNe:
1120-1797, 1724-191X

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS  ELSEVIER SCI LTD

Tipo:
Article
Páginas:
-
PubMed:
39522364
Factor de Impacto:
0,747 SCImago
Cuartil:
Q2 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • Hypoxia; Partial volume effect; PET; FMISO; HNSCC

Proyectos y Estudios Clínicos

OPTIMIZACION DE LA QUANTIFICACION EN IMAGEN POR TOMOGRAFIA POR EMISION DE POSITRONES (PET) PARA SU USO EN RADIOTERÀTIA

Investigador Principal: LUIS MARTÍ BONMATÍ

APOSTD2015/017 . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA; CONSELLERIA DE EDUCACION . 2015

Implementación de la compensación del movimiento respiratorio en el diagnóstico y tratamiento radioterápico de pacientes con cáncer de pulmón: protocolos de imagen, segmentación del tumor y garantía de calidad del tratamiento.

Investigador Principal: MONTSERRAT CARLES FARIÑA

PI22/01604 . INSTITUTO DE SALUD CARLOS III . 2023

MATTO-GBM FCAECC-Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma.

Investigador Principal: LUIS MARTÍ BONMATÍ

TRANSCAN-3 JTC2022 . COMISION EUROPEA . 2023

Contrato PFIS 2023. CARMEN SALVADOR RIBES

Investigador Principal: MONTSERRAT CARLES FARIÑA

FI23/00097 . INSTITUTO DE SALUD CARLOS III . 2024

Contrato Miguel Servet 2023. MONTSERRAT CARLES FARIÑA

Investigador Principal: MONTSERRAT CARLES FARIÑA

CP23/00106 . INSTITUTO DE SALUD CARLOS III . 2024

MATTO-GBM ISCIII-Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma.

Investigador Principal: LUIS MARTÍ BONMATÍ

AC23_1/00012 . COMISION EUROPEA . 2024

Acción de fortalecimiento institucional transversal para una medicina 5P (AFIT-5P)

Investigador Principal: JAVIER DE LA RUBIA COMOS

FORT23/00021 . INSTITUTO DE SALUD CARLOS III . 2024

BIOBANCO DEL HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE (BIOBANCO LA FE). PLATAFORMA DE BIOBANCOS Y BIOMODELOS

Investigador Principal: JOSÉ VICENTE CERVERA ZAMORA

PT23/00166 . INSTITUTO DE SALUD CARLOS III . 2024

Cita

Compartir